Results 211 to 220 of about 149,549 (315)

Langerhans cells in keratoacanthoma

Journal of the Formosan Medical Association, 2015
Wu, Yang-Che, Chang, Julia Yu-Fong, Wang, Yi-Ping, Chiang, Chun-Pin   +3 more
openaire   +3 more sources

Frequency and Implications of High‐Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort

Clinical and Translational Science, Volume 18, Issue 5, May 2025.
ABSTRACT Pharmacogenomics remains underutilized in pediatric oncology, despite the existence of evidence‐based guidelines. Implementation of pharmacogenomics‐informed prescribing could improve medication safety and efficacy in pediatric oncology patients, who are at high risk of adverse drug reactions.
Claire Moore, Andreas Halman, Tayla Stenta, Dhrita Khatri, Elizabeth Williams, Roxanne Dyas, Julian Stolper, David A. Elliott, Rachel Conyers   +8 more
wiley   +1 more source

High CCR6 expression increases the risk of pediatric Langerhans cell histiocytosis. [PDF]

Blood Sci
Yao X, Zheng Y, Xia J, Zhang M, Zheng W, Zhang R, Wu Y, He L, Liu H.   +8 more
europepmc   +1 more source

A Novel Polymersome Nanocarrier Promotes Anti‐Tumour Immunity by Improved Priming of CD8 + T Cells

Immunology, Volume 175, Issue 1, Page 21-35, May 2025.
Here, we show that subcutaneous injection of novel artificial cell membrane (ACM) polymersomes loaded with tumour‐specific antigens or peptides, such as OVA, results in efficient anti‐tumour immune responses. In both, a therapeutic and a prophylactic model, we found that ACMs were efficiently taken up by antigen presenting cells, such as dendritic ...
Regine J. Dress, William W. Ho, Victor Ho, Jian Hang Lam, Fabien M. Décaillot, Gaurav Sinsinbar, Jenetta Soo, Gowshika Rengasamy, Amit Kumar Khan, Thomas Andrew Cornell, Teck Wan Chia, Shrinivas Venkataraman, Madhavan Nallani, Florent Ginhoux   +13 more
wiley   +1 more source

[¹⁸F]FDG PET/CT of Langerhans Cell Histiocytosis with Vertebra Plana. [PDF]

Diagnostics (Basel)
Speicher T, Bastian MB, Christofyllakis K, Rosar F, Ezziddin S, Burgard C.   +5 more
europepmc   +1 more source

The Functional Role of Langerhans Cells

, 1980
Georg Stingl, Stephen I. Katz, Ira Green, Ethan M. Shevach   +3 more
openalex   +1 more source

Darier disease: Current insights and challenges in pathogenesis and management

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 5, Page 942-951, May 2025.
Darier disease (DD) is characterized by the following: Disrupted Ca2+ gradients, impaired desmosomes, impaired keratinocyte differentiation, type 17 inflammation, DC and LC ↓, Th17 cells ↑. DD treatment: First line: keratinocyte focused and/or anti‐inflammatory. Second line: experimental approaches like specific targeting of the inflammatory infiltrate.
Monika Ettinger, Susanne Kimeswenger, Isabella Deli, Judith Traxler, Sabine Altrichter, Petar Noack, Jakob D. Wikstrom, Emmanuella Guenova, Wolfram Hoetzenecker   +8 more
wiley   +1 more source

Langerhans cell histiocytosis in an adult patient with upper jaw and pulmonary involvement: A case report. [PDF]

Open Life Sci
Xiong Y, Xu F.
europepmc   +1 more source

Responses of Canine Lymphocytes to Allogeneic and Autologous Islets of Langerhans in Mixed Cell Cultures [PDF]

, 1981
Alexander Rabinovitch, Laphalle Fuller, Daniel H. Mintz, Walter Severyn, Jack Noel, C. Flaa, George Kyriakides, Joshua Miller   +7 more
openalex   +1 more source

Langerhans Cell Histiocytosis Presenting in an Adult Patient With a Pleural Effusion. [PDF]

Cureus
Loeza-Suárez J, Huertas-Castañeda PX, Toledo-Carrasquedo JM, Trejo-Tejas A, Monroy-Chargoy A.   +4 more
europepmc   +1 more source